Sunbelt Securities, Inc. Gilead Sciences, Inc. Transaction History

Sunbelt Securities, Inc.

$836 Million
Q1 2024

A detailed history of Sunbelt Securities, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sunbelt Securities, Inc. holds 11,603 shares of GILD stock, worth $841,913. This represents 0.1% of its overall portfolio holdings.

Number of Shares

11,603

Previous 9,177 26.44%

Holding current value

$841,913

Previous $743,000 14.27%

% of portfolio

0.1%

Previous 0.1%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	BUY	$71.58 - $87.29 $173,653 - $211,765	2,426 Added 26.44%	11,603 $849,000
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $5,421 - $6,148	74 Added 0.81%	9,177 $743,000
Q3 2023 Dec 11, 2023	SELL	$73.94 - $80.67 $14,270 - $15,569	-193 Reduced 2.08%	9,103 $682,000
Q2 2023 Aug 15, 2023	BUY	$76.01 - $86.7 $35,116 - $40,055	462 Added 5.23%	9,296 $716,000
Q1 2023 May 17, 2023	BUY	$77.31 - $88.08 $2,551 - $2,906	33 Added 0.37%	8,834 $732,000

Q4 2022 Feb 08, 2023	BUY	$62.32 - $89.47 $12,027 - $17,267	193 Added 2.24%	8,801 $755,000
Q3 2022 Nov 21, 2022	BUY	$59.54 - $68.01 $28,519 - $32,576	479 Added 5.89%	8,608 $531,000
Q2 2022 Oct 03, 2022	BUY	$57.72 - $65.01 $5,310 - $5,980	92 Added 1.14%	8,129 $502,000
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $60,989 - $76,426	-1,053 Reduced 11.58%	8,037 $479,000
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $34,840 - $39,544	537 Added 6.28%	9,090 $579,000
Q2 2021 Jul 29, 2021	SELL	$63.47 - $69.35 $626,766 - $684,831	-9,875 Reduced 53.59%	8,553 $587,000
Q1 2021 May 27, 2021	BUY	$60.0 - $68.46 $605,100 - $690,419	10,085 Added 120.88%	18,428 $1.19 Million
Q4 2020 Feb 09, 2021	BUY	$56.65 - $64.55 $7,647 - $8,714	135 Added 1.64%	8,343 $486,000
Q3 2020 Nov 17, 2020	SELL	$62.1 - $78.08 $5,464 - $6,871	-88 Reduced 1.06%	8,208 $519,000
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $289 - $336	4 Added 0.05%	8,296 $640,000
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $699,201 - $895,576	-11,164 Reduced 57.38%	8,292 $620,000
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $43,873 - $48,259	-712 Reduced 3.53%	19,456 $316 Million
Q3 2019 Nov 15, 2019	BUY	$62.51 - $69.0 $624,849 - $689,724	9,996 Added 98.27%	20,168 $1.28 Million
Q2 2019 Aug 01, 2019	BUY	$61.87 - $69.38 $134,196 - $150,485	2,169 Added 27.1%	10,172 $687,000
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $28,576 - $32,012	457 Added 6.06%	8,003 $520,000
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $29,180 - $38,078	-482 Reduced 6.0%	7,546 $472,000
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $5,488 - $6,076	-77 Reduced 0.95%	8,028 $620,000
Q2 2018 Aug 08, 2018	BUY	$64.88 - $75.68 $62,674 - $73,106	966 Added 13.53%	8,105 $574,000
Q1 2018 May 09, 2018	SELL	$72.84 - $88.8 $7,065 - $8,613	-97 Reduced 1.34%	7,139 $538,000
Q4 2017 Feb 06, 2018	BUY	$71.15 - $83.52 $514,841 - $604,350	7,236	7,236 $518,000

Others Institutions Holding GILD

# of Institutions

1,892

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $90.9B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sunbelt Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sunbelt Securities, Inc. with notifications on news.

Account

Sunbelt Securities, Inc. Gilead Sciences, Inc. Transaction History